{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:46:49Z","timestamp":1776728809062,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epigenetic aging bridges the gap between biological and chronological age by exploiting DNA methylation (DNAm) patterns. Over the past decade, successive DNAm-based clocks have been introduced, beginning with the first-generation Horvath and Hannum models and extending to second-generation PhenoAge and the GrimAge family; complementary measures include DNAm-estimated telomere length and mitotic indices such as epiTOC\/pcgtAge. We previously conducted a side-by-side evaluation of these metrics in colorectal cancer using publicly available data from The Cancer Genome Atlas (TCGA) COAD and READ cohorts, but an equally systematic assessment in breast cancer has been lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Here, using TCGA-BRCA tumor methylomes linked to clinical data (analytic n\u2009=\u2009781), we compared seven metrics (Horvath, Hannum, PhenoAge, GrimAge1, GrimAge2, epiTOC\/pcgtAge, DNAmTL) via Kaplan\u2013Meier grouping (median and tertiles) and Cox models adjusted for menopausal status, age at diagnosis, receptor subtype, stage, race, and ethnicity, with overall survival truncated at 4000\u00a0days. Our analysis reproduced expected benchmark patterns: Triple Negative Breast Cancer (TNBC) had the worst outcomes, Luminal A the best, and higher stage and older age predicted poorer survival, supporting analytic validity. We found first-generation clocks did not separate survival, whereas PhenoAge and GrimAge2 stratified outcomes; in multivariable analyses, only GrimAge1 provided independent prognostic information. DNAmTL was inversely associated with mortality in univariate models, and epiTOC stratified tertiles but showed wide, nonsignificant Cox estimates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Second-generation clocks demonstrated stronger prognostic signal than first-generation models in unadjusted analyses. Among them, GrimAge1 retained independent prognostic value beyond established clinicopathologic factors in breast cancer, supporting further external validation with richer covariates to refine clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13148-026-02102-3","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:20:25Z","timestamp":1776727225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Later-generation epigenetic aging clocks outperform first-generation models in predicting survival in TCGA breast cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Xianglong","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Yon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"6","key":"2102_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","volume":"19","author":"S Horvath","year":"2018","unstructured":"Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018;19(6):371\u201384.","journal-title":"Nat Rev Genet"},{"issue":"10","key":"2102_CR2","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):3156.","journal-title":"Genome Biol"},{"issue":"2","key":"2102_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2012.10.016","volume":"49","author":"G Hannum","year":"2013","unstructured":"Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49(2):359\u201367.","journal-title":"Mol Cell"},{"issue":"1","key":"2102_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13059-019-1824-y","volume":"20","author":"CG Bell","year":"2019","unstructured":"Bell CG, Lowe R, Adams PD, Baccarelli AA, Beck S, Bell JT, et al. DNA methylation aging clocks: challenges and recommendations. Genome Biol. 2019;20(1):249.","journal-title":"Genome Biol"},{"issue":"4","key":"2102_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.18632\/aging.101414","volume":"10","author":"ME Levine","year":"2018","unstructured":"Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573\u201391.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"2102_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.18632\/aging.101684","volume":"11","author":"AT Lu","year":"2019","unstructured":"Lu AT, Quach A, Wilson JG, Reiner AP, Aviv A, Raj K, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019;11(2):303\u201327.","journal-title":"Aging (Albany NY)"},{"issue":"23","key":"2102_CR7","first-page":"9484","volume":"14","author":"AT Lu","year":"2022","unstructured":"Lu AT, Binder AM, Zhang J, Yan Q, Reiner AP, Cox SR, et al. DNA methylation GrimAge version 2. Aging (Albany NY). 2022;14(23):9484\u2013549.","journal-title":"Aging (Albany NY)"},{"issue":"16","key":"2102_CR8","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.18632\/aging.102173","volume":"11","author":"AT Lu","year":"2019","unstructured":"Lu AT, Seeboth A, Tsai PC, Sun D, Quach A, Reiner AP, et al. DNA methylation-based estimator of telomere length. Aging (Albany NY). 2019;11(16):5895\u2013923.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"2102_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13059-016-1064-3","volume":"17","author":"Z Yang","year":"2016","unstructured":"Yang Z, Wong A, Kuh D, Paul DS, Rakyan VK, Leslie RD, et al. Correlation of an epigenetic mitotic clock with cancer risk. Genome Biol. 2016;17(1):205.","journal-title":"Genome Biol"},{"key":"2102_CR10","doi-asserted-by":"publisher","DOI":"10.1200\/GO.22.00354","volume":"9","author":"NS El Saghir","year":"2023","unstructured":"El Saghir NS, Khalil LE, El Dick J, Atwani RW, Safi N, Charafeddine M, et al. Improved survival of young patients with breast cancer 40 years and younger at diagnosis. JCO Glob Oncol. 2023;9:e2200354.","journal-title":"JCO Glob Oncol"},{"issue":"7418","key":"2102_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Comprehensive molecular portraits of human breast tumours","year":"2012","unstructured":"Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370.","journal-title":"Nature"},{"issue":"7","key":"2102_CR12","first-page":"1624","volume":"17","author":"SY Jung","year":"2025","unstructured":"Jung SY, Pellegrini M, Tan X, Yu H. Epigenetic age and accelerated aging phenotypes: a tumor biomarker for predicting colorectal cancer. Aging (Albany NY). 2025;17(7):1624\u201366.","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"2102_CR13","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.62347\/MXWJ1398","volume":"14","author":"SY Jung","year":"2024","unstructured":"Jung SY, Yu H, Tan X, Pellegrini M. Novel DNA methylation-based epigenetic signatures in colorectal cancer from peripheral blood leukocytes. Am J Cancer Res. 2024;14(5):2253\u201371.","journal-title":"Am J Cancer Res"},{"issue":"10","key":"2102_CR14","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363\u20139.","journal-title":"Bioinformatics"},{"issue":"10","key":"2102_CR15","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/bioinformatics\/btu029","volume":"30","author":"EA Houseman","year":"2014","unstructured":"Houseman EA, Molitor J, Marsit CJ. Reference-free cell mixture adjustments in analysis of DNA methylation data. Bioinformatics. 2014;30(10):1431\u20139.","journal-title":"Bioinformatics"},{"key":"2102_CR16","doi-asserted-by":"publisher","first-page":"2290120","DOI":"10.1155\/2021\/2290120","volume":"2021","author":"G D'Arrigo","year":"2021","unstructured":"D\u2019Arrigo G, Leonardis D, Abd ElHafeez S, Fusaro M, Tripepi G, Roumeliotis S. Methods to analyse time-to-event data: the kaplan-meier survival curve. Oxid Med Cell Longev. 2021;2021:2290120.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"2102_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/me.2010-0164","volume":"25","author":"DJ Toft","year":"2011","unstructured":"Toft DJ, Cryns VL. Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. Mol Endocrinol. 2011;25(2):199\u2013211.","journal-title":"Mol Endocrinol"},{"issue":"5","key":"2102_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1634\/theoncologist.2017-0535","volume":"23","author":"JJ Gao","year":"2018","unstructured":"Gao JJ, Swain SM. Luminal a breast cancer and molecular assays: a review. Oncologist. 2018;23(5):556\u201365.","journal-title":"Oncologist"},{"key":"2102_CR19","doi-asserted-by":"publisher","first-page":"1105689","DOI":"10.3389\/fgene.2023.1105689","volume":"14","author":"C Ren","year":"2023","unstructured":"Ren C, Gao A, Fu C, Teng X, Wang J, Lu S, et al. The biomarkers related to immune infiltration to predict distant metastasis in breast cancer patients. Front Genet. 2023;14:1105689.","journal-title":"Front Genet"},{"issue":"1","key":"2102_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jama.2010.897","volume":"304","author":"P Willeit","year":"2010","unstructured":"Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandst\u00e4tter A, et al. Telomere length and risk of incident cancer and cancer mortality. JAMA. 2010;304(1):69\u201375.","journal-title":"JAMA"},{"issue":"1","key":"2102_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41419-024-06454-7","volume":"15","author":"M Liu","year":"2024","unstructured":"Liu M, Zhang Y, Jian Y, Gu L, Zhang D, Zhou H, et al. The regulations of telomerase reverse transcriptase (TERT) in cancer. Cell Death Dis. 2024;15(1):90.","journal-title":"Cell Death Dis"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02102-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02102-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02102-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:20:26Z","timestamp":1776727226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02102-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2102"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02102-3","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}